*SB0209.2*
Reprinted
January 25, 2022
SENATE BILL No. 209
_____
DIGEST OF SB 209 (Updated January 24, 2022 3:48 pm - DI 106)
Citations Affected: IC 15-15; IC 24-4; IC 35-31.5; IC 35-48.
Synopsis: Drug schedules. Adds specified substances to the scheduled
list of controlled substances. Replaces references to "delta-9 THC" with
"THC".
Effective: July 1, 2022.
Young M
January 6, 2022, read first time and referred to Committee on Corrections and Criminal
Law.
January 20, 2022, amended, reported favorably — Do Pass.
January 24, 2022, read second time, amended, ordered engrossed.
SB 209—LS 6921/DI 92 Reprinted
January 25, 2022
Second Regular Session of the 122nd General Assembly (2022)
PRINTING CODE. Amendments: Whenever an existing statute (or a section of the Indiana
Constitution) is being amended, the text of the existing provision will appear in this style type,
additions will appear in this style type, and deletions will appear in this style type.
Additions: Whenever a new statutory provision is being enacted (or a new constitutional
provision adopted), the text of the new provision will appear in this style type. Also, the
word NEW will appear in that style type in the introductory clause of each SECTION that adds
a new provision to the Indiana Code or the Indiana Constitution.
Conflict reconciliation: Text in a statute in this style type or this style type reconciles conflicts
between statutes enacted by the 2021 Regular Session of the General Assembly.
SENATE BILL No. 209
A BILL FOR AN ACT to amend the Indiana Code concerning
criminal law and procedure.
Be it enacted by the General Assembly of the State of Indiana:
1 SECTION 1. IC 15-15-13-6.5, AS ADDED BY P.L.190-2019,
2 SECTION 7, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
3 JULY 1, 2022]: Sec. 6.5. As used in this chapter, "hemp product"
4 means a product derived from, or made by, processing hemp plants or
5 plant parts including derivatives, extracts, cannabinoids, isomers, acids,
6 salts, and salts of isomers. However, the term does not include:
7 (1) smokable hemp (as defined by IC 35-48-1-26.6); or
8 (2) products that contain a total delta-9-tetrahydrocannabinol
9 tetrahydrocannabinol concentration of more than three-tenths
10 of one percent (0.3%) by weight.
11 SECTION 2. IC 24-4-21-3, AS AMENDED BY P.L.190-2019,
12 SECTION 24, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
13 JULY 1, 2022]: Sec. 3. A person may distribute low THC hemp extract
14 in Indiana only if the distributor has a certificate of analysis prepared
15 by an independent testing laboratory showing:
16 (1) that the low THC hemp extract is the product of a batch tested
17 by the independent testing laboratory;
SB 209—LS 6921/DI 92 2
1 (2) that the independent testing laboratory determined that the
2 batch contained not more than three-tenths percent (0.3%) total
3 delta-9-tetrahydrocannabinol tetrahydrocannabinol (THC),
4 including precursors and isomers, by weight, based on the testing
5 of a random sample of the batch; and
6 (3) the cannabidiol percent present of the low THC hemp extract.
7 SECTION 3. IC 24-4-21-4, AS ADDED BY P.L.153-2018,
8 SECTION 9, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
9 JULY 1, 2022]: Sec. 4. (a) Except as provided in subsection (b), low
10 THC hemp extract must be distributed in packaging that contains the
11 following information:
12 (1) A scannable bar code or QR code linked to a document that
13 contains information with respect to the manufacture of the low
14 THC hemp extract, including the:
15 (A) batch identification number;
16 (B) product name;
17 (C) batch date;
18 (D) expiration date, which must be not more than two (2) years
19 from the date of manufacture;
20 (E) batch size;
21 (F) total quantity produced;
22 (G) ingredients used, including the:
23 (i) ingredient name;
24 (ii) name of the company that manufactured the ingredient;
25 (iii) company or product identification number or code, if
26 applicable; and
27 (iv) ingredient lot number; and
28 (H) download link for a certificate of analysis for the low THC
29 hemp extract.
30 (2) The batch number.
31 (3) The Internet address of a web site to obtain batch information.
32 (4) The expiration date.
33 (5) The number of milligrams of low THC hemp extract.
34 (6) The manufacturer.
35 (7) The fact that the product contains not more than three-tenths
36 percent (0.3%) total delta-9-tetrahydrocannabinol
37 tetrahydrocannabinol (THC), including precursors and isomers,
38 by weight.
39 (b) Before July 1, 2018, low THC hemp extract may be distributed
40 in Indiana without having met the requirements described in subsection
41 (a).
42 SECTION 4. IC 35-31.5-2-321, AS AMENDED BY P.L.61-2020,
SB 209—LS 6921/DI 92 3
1 SECTION 2, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
2 JULY 1, 2022]: Sec. 321. "Synthetic drug" means:
3 (1) a substance containing one (1) or more of the following
4 chemical compounds, including an analog of the compound and
5 its isomers, salts, and salts of isomers:
6 (A) JWH-015 ((2-Methyl-1-propyl-1H-
7 indol-3-yl)-1-naphthalenylmethanone).
8 (B) JWH-018 (1-pentyl-3-(1-naphthoyl)indole).
9 (C) JWH-019 (1-hexyl-3-(naphthalen-1-oyl)indole).
10 (D) JWH-073 (naphthalen-1-yl-(1-butylindol-3-yl)methanone).
11 (E) JWH-081 (4-methoxynaphthalen- 1-yl- (1-pentylindol-
12 3-yl)methanone).
13 (F) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
14 (G) JWH-200 ((1-(2-morpholin-4-ylethyl)indol-3-yl)-
15 naphthalen-1-yl-methanone).
16 (H) JWH-250 (1-pentyl-3-(2-methoxyphenylacetyl)indole).
17 (I) JWH-251 (1-pentyl-3-(2-methylphenylacetyl)indole).
18 (J) JWH-398 (1-pentyl-3-(4-chloro-1-naphthoyl)indole).
19 (K) HU-210 ((6aR,10aR)- 9-(Hydroxymethyl)- 6,6-dimethyl-
20 3-(2-methyloctan-2-yl)-
21 6a,7,10,10a-tetrahydrobenzo [c]chromen- 1-ol).
22 (L) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)- 6,6-dimethyl-
23 3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydrobenzo
24 [c]chromen-1-ol).
25 (M) HU-308 ([(1R,2R,5R)-2-[2,6-dimethoxy-4-
26 (2-methyloctan- 2-yl)phenyl]-
27 7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl] methanol).
28 (N) HU-331 (3-hydroxy-2- [(1R,6R)-3-methyl-6-
29 (1-methylethenyl)-2 -cyclohexen-1-yl]-5
30 -pentyl-2,5-cyclohexadiene-1,4-dione).
31 (O) CP 55,940
32 (2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl) cyclohexyl]-
33 5- (2-methyloctan-2-yl)phenol).
34 (P) CP 47,497 (2-[(1R,3S)-3-hydroxycyclohexyl]- 5-
35 (2-methyloctan-2-yl)phenol) and its homologues, or
36 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)
37 phenol), where side chain n=5, and homologues where side
38 chain n=4, 6, or 7.
39 (Q) WIN 55212-2
40 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)
41 pyrrolo [1,2,3-de)- 1,4- benzoxazin-
42 6-yl]-1-napthalenylmethanone).
SB 209—LS 6921/DI 92 4
1 (R) RCS-4 ((4-methoxyphenyl)
2 (1-pentyl-1H-indol-3-yl)methanone).
3 (S) RCS-8 (1-(1-(2-cyclohexylethyl)-1H-
4 indol-3-yl)-2-(2-methoxyphenyl)ethanone).
5 (T) 4-Methylmethcathinone. Other name: mephedrone.
6 (U) 3,4-Methylenedioxymethcathinone. Other name:
7 methylone.
8 (V) Fluoromethcathinone.
9 (W) 4-Methoxymethcathinone. Other name: methedrone.
10 (X) 4-Ethylmethcathinone (4-EMC).
11 (Y) Methylenedioxypyrovalerone. Other name: MDPV.
12 (Z) JWH-007, or 1-pentyl-2-methyl-3-(1-naphthoyl)indole.
13 (AA) JWH-098, or
14 1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole.
15 (BB) JWH-164, or
16 1-pentyl-3-(7-methoxy-1-naphthoyl)indole.
17 (CC) JWH-210, or 1-pentyl-3-(4-ethyl-1-naphthoyl)indole.
18 (DD) JWH-201, or
19 1-pentyl-3-(4-methoxyphenylacetyl)indole.
20 (EE) JWH-203, or 1-pentyl-3-(2-chlorophenylacetyl)indole.
21 (FF) AM-694, or
22 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole.
23 (GG) CP 50,556-1, or
24 [(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpe
25 ntan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1
26 -yl] acetate.
27 (HH) Dimethylheptylpyran, or DMHP.
28 (II) 4-Methyl-alpha-pyrrolidinobutiophenone, or MPBP.
29 (JJ) 6-APB [6-(2-aminopropyl)benzofuran].
30 (LL) 7-hydroxymitragynine.
31 (MM) á-PPP [á-pyrrolidinopropiophenone].
32 (NN) á-PVP (desmethylpyrovalerone).
33 (OO) AM-251.
34 (PP) AM-1241.
35 (QQ) AM-2201.
36 (RR) AM-2233.
37 (SS) Buphedrone (á-methylamino-butyrophenone (MABP)).
38 (TT) Butylone.
39 (UU) CP-47,497-C7.
40 (VV) CP-47,497-C8.
41 (WW) Desoxypipradol.
42 (XX) Ethylone.
SB 209—LS 6921/DI 92 5
1 (YY) Eutylone.
2 (ZZ) Flephedrone.
3 (AAA) JWH-011.
4 (BBB) JWH-020.
5 (CCC) JWH-022.
6 (DDD) JWH-030.
7 (EEE) JWH-182.
8 (FFF) JWH-302.
9 (GGG) MDAI [5,6-methylenedioxy-2-aminoindane].
10 (HHH) Mitragynine.
11 (III) Naphyrone.
12 (JJJ) Pentedrone.
13 (LLL) Pentylone.
14 (MMM) Methoxetamine
15 [2-(3-methoxyphenyl)-2-(ethylamino)- cyclohexanone].
16 (NNN) A796,260 [1-(2-morpholin-4-ylethyl)-1H-indol-3-yl]-
17 (2,2,3,3-tetramethylcyclopropyl)methanone].
18 (OOO) AB-001[(1s,3s)-admantan-1-yl)
19 (1-pentyl-1H-indol-3-yl)methanone] or [1-Pentyl-3-
20 (1-adamantoyl)indole].
21 (PPP) AM-356 [Methanandamide].
22 (QQQ) AM 1248 [1-[(1-methyl-2- piperidinyl) methyl]-
23 1H-indol-3-yl] tricyclo[3.3.1.13,7] dec-1-yl-methanone]or
24 [(1-[(N-methylpiperindin-2-yl)
25 Methyl]-3-(Adamant-1-oyl)indole)].
26 (RRR) AM 2233 Azepane isomer [(2-iodophenyl)
27 (1-(1-methylazepan-3-yl)- 1H-indol-3-yl)methanone].
28 (SSS) CB-13 [1-Naphthalenyl
29 [4-(pentyoxy)- 1-naphthalenyl]methanone].
30 (TTT) UR-144 [(1-pentyl-1H-indol-3-yl)
31 (2,2,3,3-tetramethylcyclopropyl)-methanone].
32 (UUU) URB 597 [(3'-(aminocarbonyl) [1,1'-biphenyl]-3-yl)-
33 cyclohexylcarbamate].
34 (VVV) URB602 [[1,1'-biphenyl]- 3-yl-carbamic acid,
35 cyclohexyl ester].
36 (WWW) URB 754 [6-methyl-2-[(4-methylphenyl)
37 amino]-1-benzoxazin-4-one].
38 (XXX) XLR-11 or 5-fluoro UR-144
39 (1-(5-fluoropentyl)-1H-indol-3-yl)
40 (2,2,3,3-tetramethylcyclopropyl)methanone].
41 (YYY) AKB48 (Other names include:
42 N-Adamantyl-1-pentyl-1H-Indazole-3-carboxamide;
SB 209—LS 6921/DI 92 6
1 1-pentyl-N-tricyclo[3.3.1.13.7]dec-1-yl-1H-indazole-3-
2 carboxamide).
3 (ZZZ) 25I-NBOMe (Other names include:
4 4-Iodo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-
5 benzeneethanamine);
6 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
7 methyl]ethanamine).
8 (AAAA) 2C-C-NBOMe (Other names include: 25C-NBOMe;
9 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
10 methyl]ethanamine;
11 2,5-Dimethoxy-4-chloro-N-(2-methoxybenzyl)
12 phenethylamine).
13 (BBBB) 2NE-1 (Other names include: 1-Pentyl-3-
14 (1-adamantylamido)indole).
15 (CCCC) STS-135 (Other names include:
16 N-Adamantyl-1-fluoropentylindole-3- carboxamide
17 (1-5-fluoropentyl)-N-tricyclo[3.3.1.13.7]dec-1-yl-1H-
18 indole-3-carboxamide).
19 (DDDD) PB-22 (Other names include: 1-Pentyl-8-quinolinlyl
20 ester-1H-indole-2-carboxylic acid).
21 (EEEE) 5-Fluoro-PB-22 (Other names include:
22 1-(5-Fluropentyl)-8-quinolinyl ester1H-indole-3-carboxylic
23 acid).
24 (FFFF) Benocyclidine (Other names include: BCP, BTCP, and
25 Benzothiophenylcyclohexylpiperidine).
26 (GGGG) 25B-NBOMe (Other names include: 2C-B-NBOMe
27 and 4-Bromo-2,
28 5-dimenthoxy-N-[(2-Methozyphenyl)methyl]
29 benzeneethanamine).
30 (HHHH) APB (Other names include: (2-Aminopropyl)
31 Benzofuran).
32 (IIII) AB-PINACA
33 (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-
34 indazole-3-carboxamide.
35 (JJJJ) AB-FUBINACA
36 (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-
37 1H-indazole-3-carboxamide).
38 (KKKK) ADB-PINACA
39 (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-
40 indaole-3-carboxamide).
41 (LLLL) Fluoro ADBICA (N-(1-Amino-3,3-
42 dimethyl-1-oxobutan-2-yl)-(fluoropentyl)-1H-indole-3-
SB 209—LS 6921/DI 92 7
1 carboxamide).
2 (MMMM) APDB (Other names include: -EMA,
3 -Desoxy-MDA, and (2-Aminopropyl)-2,3-
4 dihydrobenzofuran).
5 (NNNN) THJ-2201 (Other names include: AM2201 indazole
6 analog, Fluoropentyl-JWH-018 indazole, and
7 5-Fluoro-THJ-018).
8 (OOOO) AM 2201 benzimidazole analog (Other names
9 include: FUBIMINA, FTHJ, and (1-(5-fluoropentyl)-1H-
10 benzo[d]imidazol-2-yl)(naphthalene-1-yl)methanone).
11 (PPPP) MN-25 (Other names include: 7-methoxy-1-
12 [2-(4-morpholinyl)ethyl]-N-[1S, 2S, 4R)-1,3,3-
13 trimethylbicyclo[2.2.1]hept-2-yl]-1H-indole-3-carboxamide
14 and UR-12).
15 (QQQQ) FUB-PB-22 (Other names include:
16 Quinolin-8-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate).
17 (RRRR) FUD-PB-22 (Other names include:
18 Naphthalen-1-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate).
19 (SSSS) 5-Fluoro-AB-PINACA (Other names include:
20 AB-PINACA 5-fluoro analog and N-(1-amino-3-methyl1-
21 oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-
22 carboxaminde).
23 (TTTT) 4-MePPP (Other names include:
24 4-methyl-alpha-pyrrolidinopropiophenone).
25 (UUUU) alpha-PBP (Other names include:
26 Alpha-pyrrolidinobutiophenone).
27 (VVVV) AB-CHMINACA (Other names include:
28 (N-[1-(aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethy
29 l)-1H-indazole-3-carboxamide).
30 (WWWW) Mexedrone
31 (3-methoxy-2-(methylamino)-1-(p-tolyl)propan-1-one).
32 (XXXX) MT-45,
33 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine).
34 (YYYY) methyl 2-(1-(5-fluoropentyl)- 1H-indazole-3-
35 carboxamido) -3,3-dimethylbutanoate [5F-ADB;
36 5F-MDMB-PINACA].
37 (ZZZZ) methyl 2-(1-(5-fluoropentyl)-1H- indazole-3-
38 carboxamido)-3-methylbutanoate [5F-AMB].
39 (AAAAA) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)
40 -1-(4-fluorobenzyl)- 1H-indazole-3-carboxamide
41 [ADB-FUBINACA].
42 (BBBBB) N-(adamantan-1-yl)-1-(5-fluoropentyl)-
SB 209—LS 6921/DI 92 8
1 1H-indazole-3- carboxamide [5F-APINACA, 5F-AKB48].
2 (CCCCC) methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-
3 carboxamido)-3,3-dimethylbutanoate [MDMB-CHMICA,
4 MMB-CHMINACA].
5 (DDDDD) methyl 2-(1-(4-fluorobenzyl)-
6 1H-indazole-3-carboxamido)- 3,3-dimethylbutanoate
7 [MDMB-FUBINACA].
8 (EEEEE) N-(1-amino-3,3-dimethyl-1 -oxobutan-2-yl)-1-
9 (cyclohexylmethyl)- 1H-indazole-3-carboxamide
10 [MAB-CHMINACA and ADB-CHMINACA].
11 (FFFFF) Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-
12 3-carboxamido)- 3-methylbutanoate [FUB-AMB,
13 MMB-FUBINACA, AMB-FUBINACA].
14 (GGGGG) 3,4-dichloro-N-[(1dimethylamino)cyclohexylme
15 thyl]benzamide) [AH7921].
16 (HHHHH) Naphthalen-1-yl 1-(5-fluoropentyl)-1
17 H-indole-3-carboxylate (trivial name: NM2201; CBL2201)
18 (IIIII) 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1
19 H-indazole-3-carboxamide (trivial name:
20 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINA CA;
21 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78).
22 (JJJJJ) methyl 2-(1-(cyclohexylmethyl)-1
23 H-indole-3-carboxamido)-3-methylbutanoate (trivial names:
24 MMB-CHMICA, AMB-CHMICA).
25 (KKKKK) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1
26 H-pyrrolo[2,3-b]pyridine-3-carboxamide (trivial name:
27 5F-CUMYL-P7AICA).
28 (LLLLL) N-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-p
29 entanone (N-ethylpentylone, ephylone).
30 (MMMMM) Synthetic cathinone, 1-(1,3-benzodioxol-5-yl)-2-
31 (ethylamino)- pentan-1-one (N-ethylpentylone, ephylone) and
32 its optical, positional, and geometric isomers, salts, and salts
33 of isomers.
34 (NNNNN) ethyl
35 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-
36 dimethylbutanoate (trivial name: 5F-EDMB-PINACA).
37 (OOOOO) methyl 2-(1-(5- fluoropentyl)-1H-indole-3-
38 carboxamido)-3,3-dimethylbutanoate (trivial name:
39 5F-MDMB-PICA).
40 (PPPPP) N- (adamantan- 1-yl)- 1-(4-fluorobenzyl)-
41 1H-indazole-3-carboxamide (trivial names: FUB-AKB48;
42 FUB-APINACA; AKB48 N- (4-FLUOROBENZYL)).
SB 209—LS 6921/DI 92 9
1 (QQQQQ) 1-(5- fluoropentyl)-N-(2-phenylpropan-2-yl)-
2 1H-indazole-3-carboxamide (trivial names:
3 5F-CUMYL-PINACA; SGT-25).
4 (RRRRR) (1-(4-fluorobenzyl)-1H-indol-3-
5 yl)(2,2,3,3-tetramethylcyclopropyl) methanone (trivial name:
6 FUB-144).
7 (SSSSS) 4F-MDMB-BINACA.
8 (TTTTT) N-ethylhexedrone
9 (2-(ethylamino)-1-phenylhexan-1-one).
10 (UUUUU) alpha-pyrrolidinohexanophenone
11 (1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one.
12 (VVVVV) alpha-pyrrolidinohexiophenone; trivial name:
13 a-PHP.
14 (WWWWW) 4'-methyl-alpha-pyrrolidinohexiophenone
15 (1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one.
16 (XXXXX) 4-methyl-alphaethylaminopentiophenone
17 (2-(ethylamino)-1-(4-methylphenyl)pentan-1-one; trivial
18 name: 4–MEAP.
19 (YYYYY) 4'-methyl-alphapyrrolidinohexanophenone; trivial
20 name: MPHP.
21 (ZZZZZ) alphapyrrolidinoheptaphenone
22 (1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one; trivial name: PV8.
23 (AAAAAA) 4'-chloro-alphapyrrolidinovalerophenone (1-(4-
24 chlorophenyl)-2-(pyrrolidin-1- yl)pentan-1-one.
25 (BBBBBB) 4'-chloro-alphapyrrolidinopentiophenone; trivial
26 name: 4-chloro-a-PVP.
27 (CCCCCC) 4,4'-dimethylaminorex (common name:
28 4,4'-DMAR).
29 (2) Any compound structurally derived from
30 3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane by
31 substitution at the nitrogen atom of the indole ring by alkyl,
32 haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
33 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
34 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
35 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
36 or not further substituted in the indole ring to any extent and
37 whether or not substituted in the naphthyl ring to any extent.
38 (3) Any compound structurally derived from 3-(1-naphthoyl)
39 pyrrole by substitution at the nitrogen atom of the pyrrole ring by
40 alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
41 cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl,
42 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl,
SB 209—LS 6921/DI 92 10
1 1-(N-methyl-3- morpholinyl)methyl, or tetrahydropyranylmethyl
2 group, whether or not further substituted in the pyrrole ring to any
3 extent and whether or not substituted in the naphthyl ring to any
4 extent.
5 (4) Any compound structurally derived from
6 1-(1-naphthylmethyl)indene by substitution at the 3-position of
7 the indene ring by alkyl, haloalkyl, cyanoalkyl, alkenyl,
8 cycloalkylmethyl, cycloalkylethyl,
9 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
10 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
11 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
12 or not further substituted in the indene ring to any extent and
13 whether or not substituted in the naphthyl ring to any extent.
14 (5) Any compound structurally derived from 3-phenylacetylindole
15 by substitution at the nitrogen atom of the indole ring with alkyl,
16 haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
17 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
18 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
19 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
20 or not further substituted in the indole ring to any extent and
21 whether or not substituted in the phenyl ring to any extent.
22 (6) Any compound structurally derived from
23 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position
24 of the phenolic ring by alkyl, haloalkyl, cyanoalkyl, alkenyl,
25 cycloalkylmethyl, cycloalkylethyl,
26 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
27 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
28 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
29 or not substituted in the cyclohexyl ring to any extent.
30 (7) Any compound containing a 3-(benzoyl)indole structure with
31 substitution at the nitrogen atom of the indole ring by alkyl,
32 haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
33 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
34 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
35 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
36 or not further substituted in the indole ring to any extent and
37 whether or not substituted in the phenyl ring to any extent.
38 (8) Any compound, except bupropion or a compound listed under
39 a different schedule, structurally derived from
40 2-aminopropan-1-one by substitution at the 1-position with either
41 phenyl, naphthyl, or thiophene ring systems, whether or not the
42 compound is further modified:
SB 209—LS 6921/DI 92 11
1 (A) by substitution in the ring system to any extent with alkyl,
2 alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide
3 substituents, whether or not further substituted in the ring
4 system by one or more other univalent substituents;
5 (B) by substitution at the 3-position with an acyclic alkyl
6 substituent;
7 (C) by substitution at the 2-amino nitrogen atom with alkyl,
8 dialkyl, benzyl, or methoxybenzyl groups; or
9 (D) by inclusion of the 2-amino nitrogen atom in a cyclic
10 structure.
11 (9) Any compound structurally derived from 3-tetramethyl
12 cyclopropanoylindole with substitution at the nitrogen atom of the
13 indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,
14 cycloalkylmethyl, cycloalkylethyl,
15 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl) ethyl,
16 1-(N-methyl-2-pyrrolidinyl) methyl, 1-(N-methyl-3-
17 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
18 or not further substituted in the indole ring to any extent and
19 whether or not substituted in the tetramethylcyclopropyl ring to
20 any extent.
21 (10) Any compound containing a N-(1-adamantyl)-
22 1H-indazole-3-carboxamide structure with substitution at the
23 nitrogen atom of the indazole ring by an alkyl, haloalkyl,
24 cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
25 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl,
26 1-(N-methyl-2-pyrrolidinyl)methyl,
27 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
28 group, whether or not further substituted at the nitrogen atom of
29 the carboxamide to any extent, whether or not further substituted
30 in the indazole ring to any extent, and whether or not further
31 substituted on the adamantyl ring system to any extent. An
32 example of this structural class includes AKB48.
33 (11) Any compound containing a N-(1-adamantyl)-
34 1H-indole-3-carboxamide structure with substitution at the
35 nitrogen atom of the indole ring by an alkyl, haloalkyl,
36 cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
37 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl,
38 1-(N-methyl-2-pyrrolidinyl)methyl,
39 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
40 group, whether or not further substituted at the nitrogen atom of
41 the carboxamide to any extent, whether or not further substituted
42 in the indole ring to any extent, and whether or not further
SB 209—LS 6921/DI 92 12
1 substituted on the adamantyl ring system to any extent. An
2 example of this structural class includes STS-135.
3 (12) Any compound containing a 3-(1-adamantoyl)indole
4 structure with substitution at the nitrogen atom of the indole ring
5 by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
6 cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl, or
7 2-(4-morpholinyl)ethyl, 1-(N-methyl-2- pyrrolidinyl)methyl,
8 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
9 group, whether or not further substituted on the adamantyl ring
10 system to any extent. An example of this structural class includes
11 AM-1248.
12 (13) Any compound determined to be a synthetic drug by rule
13 adopted under IC 25-26-13-4.1.
14 SECTION 5. IC 35-48-1-17.4, AS ADDED BY P.L.61-2020,
15 SECTION 3, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
16 JULY 1, 2022]: Sec. 17.4. (a) Except as provided in subsections (b)
17 and (c), "isomer" means an optical isomer.
18 (b) "Isomer", as used in IC 35-48-2-4(d), means an optical,
19 positional, or geometric isomer.
20 (c) "Isomer", as used in section 7 of this chapter, means an optical
21 or geometric isomer. "Isomer" means an optical, positional, or
22 geometric isomer.
23 SECTION 6. IC 35-48-1-17.5, AS AMENDED BY P.L.190-2019,
24 SECTION 28, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
25 JULY 1, 2022]: Sec. 17.5. (a) "Low THC hemp extract" means a
26 substance or compound that:
27 (1) is derived from or contains any part of the plant Cannabis
28 sativa L. that meets the definition of hemp under IC 15-15-13-6;
29 (2) contains not more than three-tenths percent (0.3%) total
30 delta-9-tetrahydrocannabinol tetrahydrocannabinol (THC),
31 including precursors and isomers, by weight; and
32 (3) contains no other controlled substances.
33 (b) The term does not include:
34 (1) the harvested reproductive organ, whether immature or
35 mature, of the female hemp plant; or
36 (2) smokable hemp.
37 SECTION 7. IC 35-48-2-4, AS AMENDED BY P.L.10-2021,
38 SECTION 1, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
39 JULY 1, 2022]: Sec. 4. (a) The controlled substances listed in this
40 section are included in schedule I.
41 (b) Opiates. Any of the following opiates, including their isomers,
42 esters, ethers, salts, and salts of isomers, esters, and ethers, unless
SB 209—LS 6921/DI 92 13
1 specifically excepted by rule of the board or unless listed in another
2 schedule, whenever the existence of these isomers, esters, ethers, and
3 salts is possible within the specific chemical designation:
4 4-fluoroisobutyryl fentanyl
5 Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-
6 piperidinyl]-N-phenylacetamide) (9815)
7 Acetyl fentanyl (Other names include:
8 N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)
9 Acetylmethadol (9601)
10 Acrylfentanyl. Other name: N-(1-phenethylpiperidin-4-yl)-
11 N-phenylacrylamide
12 Allylprodine (9602)
13 Alpha-methylthiofentanyl (N-[1-methyl-2-(2-
14 thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) (9832)
15 Alphacetylmethadol (9603)
16 Alphameprodine (9604)
17 Alphamethadol (9605)
18 Alphamethylfentanyl (9814)
19 Benzethidine (9606)
20 Beta-hydroxy-3-methylfentanyl (9831). Other name:
21 N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl
22 ]-N-phenylpropanamide
23 Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-
24 phenethyl)-4-piperidinyl]-N-phenylpropanamide) (9830)
25 Betacetylmethadol (9607)
26 Betameprodine (9608)
27 Betamethadol (9609)
28 Betaprodine (9611)
29 Brorphine
30 2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1yl)-N,N-di
31 ethylethan-1-amine (butonitazene)
32 Clonitazene (9612)
33 Cyclopentyl fentanyl. Other name:
34 N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide
35 Dextromoramide (9613)
36 Diampromide (9615)
37 Diethylthiambutene (9616)
38 N,N-diethyl-2-(2-(4-flourobenzyl)-5-nitro-1H-benzimidazol-
39 1-yl)ethan-1-amine (flunitazene)
40 N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)e
41 than-1-amine (metodesnitazene)
42 N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidaz
SB 209—LS 6921/DI 92 14
1 ol-1-yl)ethan-1-amine (metonitazene)
2 N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidaz
3 ol-1-yl)ethan-1-amine (protonitazene)
4 Difenoxin (9168)
5 Dimenoxadol (9617)
6 Dimepheptanol (9618)
7 Dimethylthiambutene (9619)
8 Dioxaphetyl butyrate (9621)
9 Dipipanone (9622)
10 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1yl)-N,N-diethyleth
11 an-1-amine (etodesnitazene; etazene)
12 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-
13 benzimidazole (N-pyrrolidino etonitazene; etonitazepyne)
14 Ethylmethylthiambutene (9623)
15 Etonitazene (9624)
16 Etoxeridine (9625)
17 Fentanyl related substances.
18 Furanyl fentanyl.
19 Furethidine (9626)
20 Hydroxypethidine (9627)
21 Isobutyryl fentanyl. Other name:
22 N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide
23 Isotonitazene. Other name: N,N-diethyl-2-
24 (2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-
25 1-yl)ethan-1-amine)
26 Ketobemidone (9628)
27 Levomoramide (9629)
28 Levophenacylmorphan (9631)
29 Methoxyacetyl fentanyl. Other name:
30 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide
31 3-Methylfentanyl [N-[3-methyl-1-(2-phenylethyl)-4-
32 piperidyl]-N-phenyl-propanimide](9813)
33 3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-
34 piperidinyl]-N-phenylpropanamide) (9833)
35 MDMB-4en-PINACA
36 4F-MDMB-BICA; 4-fluoro MDMB-BICA; 4F-MDMB-BUTICA;
37 Methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,
38 3-dimethyl-butanoate
39 MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) (9961)
40 Morpheridine (9632)
41 N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl),
42 including any isomers, salts, or salts of isomers (9818)
SB 209—LS 6921/DI 92 15
1 N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl] 25 piperidin-4-yl]-
2 N-phenylpropionamide, also known as N-[1-[2-hydroxy-2-
3 (2-thienyl)ethyl] -4- piperidinyl]- N-phenylpropanamide,
4 (beta-hydroxythiofentanyl)
5 N-(4-chlorophenyl)- N-(1-phenethylpiperidin-4-yl) isobutyramide
6 (para-chloroisobutyryl fentanyl)
7 N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)
8 acetamide (ocfentanil)
9 N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4 -yl) butyramide
10 (para-fluorobutyryl fentanyl)
11 N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, also known
12 as N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide, (butyryl
13 fentanyl)
14 N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide (valeryl
15 fentanyl)
16 N-(4-methoxyphenyl)-N-(1-phenethylpiperidin -4-yl) butyramide
17 (para-methoxybutyryl fentanyl)
18 N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide
19 (thenylfentanyl), including any isomers, salts, or salts of isomers
20 (9834)
21 N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide (isobutyryl
22 fentanyl)
23 N-(1-phenethylpiperidin-4-yl)- Nphenylcyclopentanecarboxamide
24 (cyclopentyl fentanyl)
25 Noracymethadol (9633)
26 Norlevorphanol (9634)
27 Normethadone (9635)
28 Norpipanone (9636)
29 Ocfentanil. Other name:
30 N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)
31 acetamide
32 Ortho-fluorofentanyl or 2-fluorofentanyl. Other name:
33 N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide
34 Para-chloroisobutyryl fentanyl. Other name:
35 N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide
36 Para-fluorobutyryl fentanyl. Other name:
37 N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide
38 Para-fluorofentanyl (N-(4-fluorophenyl)-N-
39 [1-(2-phenethyl)-4-piperidinyl] propanamide (9812)
40 Para-methoxybutyryl fentanyl. Other name:
41 N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide
42 Phenadoxone (9637)
SB 209—LS 6921/DI 92 16
1 Phenampromide (9638)
2 Phenomorphan (9647)
3 Phenoperidine (9641)
4 PEPAP [1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine] (9663)
5 Piritramide (9642)
6 Proheptazine (9643)
7 Properidine (9644)
8 Propiram (9649)
9 Racemoramide (9645)
10 Tetrahydrofuranyl fentanyl. Other name:
11 N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carb
12 oxamide
13 Thiofentanyl (N-phenyl-N-[ 1-(2-thienyl)ethyl-4-
14 piperidinyl]-propanamide) (9835)
15 Tilidine (9750)
16 Trimeperidine (9646)
17 U47700 (3,4-dichloro- N- [2-dimethylamino)cyclohexyl]-
18 N-methyl- benzamide)
19 Valeryl fentanyl. Other name:
20 N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide
21 (c) Opium derivatives. Any of the following opium derivatives, their
22 salts, isomers, and salts of isomers, unless specifically excepted by rule
23 of the board or unless listed in another schedule, whenever the
24 existence of these salts, isomers, and salts of isomers is possible within
25 the specific chemical designation:
26 Acetorphine (9319)
27 Acetyldihydrocodeine (9051)
28 Benzylmorphine (9052)
29 Codeine methylbromide (9070)
30 Codeine-N-Oxide (9053)
31 Cyprenorphine (9054)
32 Desomorphine (9055)
33 Dihydromorphine (9145)
34 Drotebanol (9335)
35 Etorphine (except hydrochloride salt) (9056)
36 Heroin (9200)
37 Hydromorphinol (9301)
38 Methyldesorphine (9302)
39 Methyldihydromorphine (9304)
40 Morphine methylbromide (9305)
41 Morphine methylsulfonate (9306)
42 Morphine-N-Oxide (9307)
SB 209—LS 6921/DI 92 17
1 Myrophine (9308)
2 Nicocodeine (9309)
3 Nicomorphine (9312)
4 Normorphine (9313)
5 Pholcodine (9314)
6 Thebacon (9315)
7 (d) Hallucinogenic substances. Unless specifically excepted or
8 unless listed in another schedule, any material, compound, mixture, or
9 preparation which contains any quantity of the following
10 hallucinogenic, psychedelic, or psychogenic substances, their salts,
11 isomers, and salts of isomers whenever the existence of these salts,
12 isomers, and salts of isomers is possible within the specific chemical
13 designation (for purposes of this subsection only, the term "isomer"
14 includes the optical, position, and geometric isomers): designation:
15 (1) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine (7473). Other name:
16 TCPy.
17 (2) 4-Bromo-2, 5-Dimethoxyamphetamine (7391). Some trade or
18 other names: 4-Bromo-2, 5-Dimethoxy-a-methylphenethylamine;
19 4-Bromo-2, 5-DMA.
20 (3) 4-Bromo-2, 5-dimethoxyphenethylamine (7392). Some trade
21 or other names:
22 2-[4-bromo-2,5-dimethoxyphenyl]-1-aminoethane;
23 alpha-desmethyl DOB; 2C-B, Nexus.
24 (4) 2, 5-Dimethoxy-4-ethylamphet-amine (7399). Other name:
25 DOET.
26 (5) 2, 5-Dimethoxy-4-(n)-propylthiophenethylamine (7348).
27 Other name: 2C-T-7.
28 (6) 2, 5-Dimethoxyamphetamine (7396). Some trade or other
29 names: 2, 5-Dimethoxy-a-methylphenethylamine; 2, 5-DMA.
30 (7) 4-Methoxyamphetamine (7411). Some trade or other names:
31 4-Methoxy-a-methylphenethylamine; Paramethoxyamphetamine;
32 PMA.
33 (8) 5-Methoxy-3, 4-methylenedioxy amphetamine (7401). Other
34 Name: MMDA.
35 (9) 5-Methoxy-N, N-diisopropyltryptamine, including any
36 isomers, salts, or salts of isomers (7439). Other name:
37 5-MeO-DIPT.
38 (10) 4-methyl-2, 5-dimethoxyamphetamine (7395). Some trade
39 and other names: 4-methyl-2,
40 5-dimethoxy-a-methylphenethylamine; DOM; and STP.
41 (11) 3, 4-methylenedioxy amphetamine (7400). Other name:
42 MDA.
SB 209—LS 6921/DI 92 18
1 (12) 3,4-methylenedioxy-N-ethylamphetamine (7404). Other
2 names: N-ethyl-alpha-methyl-3,4(methylenedioxy)
3 phenethylamine; N-ethyl MDA; MDE; and MDEA.
4 (13) 3, 4-methylenedioxymethamphetamine (MDMA) (7405).
5 (14) 3, 4, 5-trimethoxy amphetamine (7390). Other name: TMA.
6 (15) Alpha-ethyltryptamine (7249). Some trade and other names:
7 Etryptamine; Monase; [alpha]-ethyl-1H-indole-3-ethanamine;
8 3-(2-aminobutyl) indole; [alpha]-ET; and AET.
9 (16) Alpha-methyltryptamine (7432). Other name: AMT.
10 (17) Bufotenine (7433). Some trade and other names:
11 3-(B-Dimethylaminoethyl)-5-hydroxyindole;
12 3-(2-dimethylaminonethyl)-5-indolol; N, N-dimethylserotonin;
13 5-hydroxy-N, N-dimethyltryptamine; mappine.
14 (18) Diethyltryptamine (7434). Some trade or other names: N,
15 N-Diethyltryptamine; DET.
16 (19) Dimethyltryptamine (7435). Some trade or other names:
17 DMT.
18 (20) Ibogaine (7260). Some trade and other names: 7-Ethyl-6, 6b,
19 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-pyrido
20 (1', 2': 1, 2, azepino 4, 5-b) indole; tabernanthe iboga.
21 (21) Lysergic acid diethylamide (7315). Other name: LSD.
22 (22) Marijuana (7360).
23 (23) Mescaline (7381).
24 (24) Parahexyl (7374). Some trade or other names:
25 3-Hexyl-1-hydroxy-7, 8, 9, 10-Tetrahydro-6, 6,
26 9-trimethyl-6H-dibenzo (b,d) pyran; Snyhexyl.
27 (25) Peyote (7415), including:
28 (A) all parts of the plant that are classified botanically as
29 lophophora williamsii lemaire, whether growing or not;
30 (B) the seeds thereof;
31 (C) any extract from any part of the plant; and
32 (D) every compound, manufacture, salt, derivative, mixture, or
33 preparation of the plant, its seeds, or extracts.
34 (26) N-ethyl-3-piperidyl benzilate (7482). Other name: DMZ.
35 (27) N-hydroxy-3,4-methylenedioxyamphetamine (7402). Other
36 names: N-hydroxy-alpha-methyl-3,4
37 (methylenedioxy)phenethylamine; and N-hydroxy MDA.
38 (28) N-methyl-3-piperidyl benzilate (7484). Other name: LBJ.
39 (29) Psilocybin (7437).
40 (30) Psilocyn (7438).
41 (31) Tetrahydrocannabinols (7370), including synthetic
42 equivalents of the substances contained in the plant, or in the
SB 209—LS 6921/DI 92 19
1 resinous extractives of Cannabis, sp. and synthetic substances,
2 derivatives, and their isomers with similar chemical structure and
3 pharmacological activity such as:
4 (A) ð
1
cis or trans tetrahydrocannabinol, and their optical
5 isomers;
6 (B) ð
6
cis or trans tetrahydrocannabinol, and their optical
7 isomers; and
8 (C) ð
3,
4 cis or trans tetrahydrocannabinol, and their optical
9 isomers.
10 Since nomenclature of these substances is not internationally
11 standardized, compounds of these structures, regardless of
12 numerical designation of atomic positions are covered. Other
13 name: THC.
14 (32) Ethylamine analog of phencyclidine (7455). Some trade or
15 other names: N-Ethyl-1-phenylcyclohexylamine;
16 (1-phenylcyclohexyl) ethylamine; N-(1-phenylcyclohexyl)
17 ethylamine; cyclohexamine; PCE.
18 (33) Pyrrolidine analog of phencyclidine (7458). Some trade or
19 other names: 1-(1-phenylcyclohexyl)-pyrrolidine; PCP
y; PHP.
20 (34) Thiophene analog of phencyclidine (7470). Some trade or
21 other names: 1-(1-(2-thienyl) cyclohexyl) piperidine; 2-Thienyl
22 Analog of Phencyclidine; TPCP.
23 (35) Salvia divinorum or salvinorin A, including:
24 (A) all parts of the plant that are classified botanically as salvia
25 divinorum, whether growing or not;
26 (B) the seeds of the plant;
27 (C) any extract from any part of the plant; and
28 (D) every compound, manufacture, salt, derivative, mixture, or
29 preparation of the plant, its seeds, or extracts.
30 (36) 5-Methoxy-N,N-Dimethyltryptamine. Some trade or other
31 names: 5-methoxy-3-[2- (dimethylamino)ethyl]indole;
32 5-MeO-DMT.
33 (37) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).
34 (38) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).
35 (39) 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C).
36 (40) 2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I).
37 (41) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl] ethanamine (2C-T-2).
38 (42) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl] ethanamine
39 (2C-T-4).
40 (43) 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H).
41 (44) 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N).
42 (45) 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P).
SB 209—LS 6921/DI 92 20
1 (46) Deschloroketamine (2-Phenyl-2-
2 (methylamino)cyclohexanone).
3 (47) 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-
4 ethyltryptamine).
5 (48) N-methyltryptamine (1H-Indole-3-ethanamine, N-methyl-).
6 (e) Depressants. Unless specifically excepted in a rule adopted by
7 the board or unless listed in another schedule, any material, compound,
8 mixture, or preparation which contains any quantity of the following
9 substances having a depressant effect on the central nervous system,
10 including its salts, isomers, and salts of isomers whenever the existence
11 of such salts, isomers, and salts of isomers is possible within the
12 specific chemical designation:
13 Etizolam (4-(2- chlorophenyl)-2- ethyl-9- methyl- 6H-
14 thieno[3,2-f] [1,2,4] triazolo[4,3-a] [1,4diazepine) (other names
15 include: Etilaam, Etizest, Depas, Etizola, Sedekopan, and
16 Pasaden)
17 Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-
18 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)
19 Gamma-hydroxybutyric acid (other names include GHB;
20 gamma-hydroxybutyrate; 4-hydroxybutanoic acid; sodium
21 oxybate; sodium oxybutyrate) (2010)
22 Mecloqualone (2572)
23 Methaqualone (2565)
24 (f) Stimulants. Unless specifically excepted or unless listed in
25 another schedule, any material, compound, mixture, or preparation that
26 contains any quantity of the following substances having a stimulant
27 effect on the central nervous system, including its salts, isomers, and
28 salts of isomers:
29 ([+/-]) cis-4-methylaminorex (([+/-])cis-4,5-
30 dihydro-4-methyl-5-phenyl-2-oxazolamine) (1590)
31 Aminorex (1585). Other names: aminoxaphen;
32 2-amino-5-phenyl-2-oxazoline; or
33 4,5-dihydro-5-phenyl-2-oxazolamine.
34 Benzylone, 1-(1,3-benzodioxol-5-yl)-2-(benzylamino)propan
35 -1-one. Synonyms: BMDP, N-benzyl methylone,
36 3,4-Methylenedioxy-Nbenzylcathinone,
37 N-benzyl-3,4-methylenedioxycathinone.
38 Cathinone (1235). Some trade or other names:
39 2-amino-1-phenyl-1-propanone; alpha-aminopropiophenone;
40 2-aminopropiophenone; and norephedrone.
41 Fenethylline (1503).
42 N-Benzylpiperazine (7493). Other names: BZP; and
SB 209—LS 6921/DI 92 21
1 1-benzylpiperazine.
2 N-ethylamphetamine (1475).
3 Methcathinone (1237). Some other trade names:
4 2-Methylamino-1-Phenylpropan-I-one; Ephedrone;
5 Monomethylpropion; UR 1431.
6 N, N-dimethylamphetamine (1480). Other names: N,
7 N-alpha-trimethyl-benzeneethanamine; and N,
8 N-alpha-trimethylphenethylamine.
9 (g) Synthetic drugs as defined in IC 35-31.5-2-321.
SB 209—LS 6921/DI 92 22
COMMITTEE REPORT
Madam President: The Senate Committee on Corrections and
Criminal Law, to which was referred Senate Bill No. 209, has had the
same under consideration and begs leave to report the same back to the
Senate with the recommendation that said bill be AMENDED as
follows:
Page 1, between the enacting clause and line 1, begin a new
paragraph and insert:
"SECTION 1. IC 35-31.5-2-321, AS AMENDED BY P.L.61-2020,
SECTION 2, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
JULY 1, 2022]: Sec. 321. "Synthetic drug" means:
(1) a substance containing one (1) or more of the following
chemical compounds, including an analog of the compound:
(A) JWH-015 ((2-Methyl-1-propyl-1H-
indol-3-yl)-1-naphthalenylmethanone).
(B) JWH-018 (1-pentyl-3-(1-naphthoyl)indole).
(C) JWH-019 (1-hexyl-3-(naphthalen-1-oyl)indole).
(D) JWH-073 (naphthalen-1-yl-(1-butylindol-3-yl)methanone).
(E) JWH-081 (4-methoxynaphthalen- 1-yl- (1-pentylindol-
3-yl)methanone).
(F) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
(G) JWH-200 ((1-(2-morpholin-4-ylethyl)indol-3-yl)-
naphthalen-1-yl-methanone).
(H) JWH-250 (1-pentyl-3-(2-methoxyphenylacetyl)indole).
(I) JWH-251 (1-pentyl-3-(2-methylphenylacetyl)indole).
(J) JWH-398 (1-pentyl-3-(4-chloro-1-naphthoyl)indole).
(K) HU-210 ((6aR,10aR)- 9-(Hydroxymethyl)- 6,6-dimethyl-
3-(2-methyloctan-2-yl)-
6a,7,10,10a-tetrahydrobenzo [c]chromen- 1-ol).
(L) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)- 6,6-dimethyl-
3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydrobenzo
[c]chromen-1-ol).
(M) HU-308 ([(1R,2R,5R)-2-[2,6-dimethoxy-4-
(2-methyloctan- 2-yl)phenyl]-
7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl] methanol).
(N) HU-331 (3-hydroxy-2- [(1R,6R)-3-methyl-6-
(1-methylethenyl)-2 -cyclohexen-1-yl]-5
-pentyl-2,5-cyclohexadiene-1,4-dione).
(O) CP 55,940
(2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl) cyclohexyl]-
5- (2-methyloctan-2-yl)phenol).
SB 209—LS 6921/DI 92 23
(P) CP 47,497 (2-[(1R,3S)-3-hydroxycyclohexyl]- 5-
(2-methyloctan-2-yl)phenol) and its homologues, or
2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)
phenol), where side chain n=5, and homologues where side
chain n=4, 6, or 7.
(Q) WIN 55212-2
((R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)
pyrrolo [1,2,3-de)- 1,4- benzoxazin-
6-yl]-1-napthalenylmethanone).
(R) RCS-4 ((4-methoxyphenyl)
(1-pentyl-1H-indol-3-yl)methanone).
(S) RCS-8 (1-(1-(2-cyclohexylethyl)-1H-
indol-3-yl)-2-(2-methoxyphenyl)ethanone).
(T) 4-Methylmethcathinone. Other name: mephedrone.
(U) 3,4-Methylenedioxymethcathinone. Other name:
methylone.
(V) Fluoromethcathinone.
(W) 4-Methoxymethcathinone. Other name: methedrone.
(X) 4-Ethylmethcathinone (4-EMC).
(Y) Methylenedioxypyrovalerone. Other name: MDPV.
(Z) JWH-007, or 1-pentyl-2-methyl-3-(1-naphthoyl)indole.
(AA) JWH-098, or
1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole.
(BB) JWH-164, or
1-pentyl-3-(7-methoxy-1-naphthoyl)indole.
(CC) JWH-210, or 1-pentyl-3-(4-ethyl-1-naphthoyl)indole.
(DD) JWH-201, or
1-pentyl-3-(4-methoxyphenylacetyl)indole.
(EE) JWH-203, or 1-pentyl-3-(2-chlorophenylacetyl)indole.
(FF) AM-694, or
1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole.
(GG) CP 50,556-1, or
[(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpe
ntan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1
-yl] acetate.
(HH) Dimethylheptylpyran, or DMHP.
(II) 4-Methyl-alpha-pyrrolidinobutiophenone, or MPBP.
(JJ) 6-APB [6-(2-aminopropyl)benzofuran].
(LL) 7-hydroxymitragynine.
(MM) á-PPP [á-pyrrolidinopropiophenone].
(NN) á-PVP (desmethylpyrovalerone).
(OO) AM-251.
SB 209—LS 6921/DI 92 24
(PP) AM-1241.
(QQ) AM-2201.
(RR) AM-2233.
(SS) Buphedrone (á-methylamino-butyrophenone (MABP)).
(TT) Butylone.
(UU) CP-47,497-C7.
(VV) CP-47,497-C8.
(WW) Desoxypipradol.
(XX) Ethylone.
(YY) Eutylone.
(ZZ) Flephedrone.
(AAA) JWH-011.
(BBB) JWH-020.
(CCC) JWH-022.
(DDD) JWH-030.
(EEE) JWH-182.
(FFF) JWH-302.
(GGG) MDAI [5,6-methylenedioxy-2-aminoindane].
(HHH) Mitragynine.
(III) Naphyrone.
(JJJ) Pentedrone.
(LLL) Pentylone.
(MMM) Methoxetamine
[2-(3-methoxyphenyl)-2-(ethylamino)- cyclohexanone].
(NNN) A796,260 [1-(2-morpholin-4-ylethyl)-1H-indol-3-yl]-
(2,2,3,3-tetramethylcyclopropyl)methanone].
(OOO) AB-001[(1s,3s)-admantan-1-yl)
(1-pentyl-1H-indol-3-yl)methanone] or [1-Pentyl-3-
(1-adamantoyl)indole].
(PPP) AM-356 [Methanandamide].
(QQQ) AM 1248 [1-[(1-methyl-2- piperidinyl) methyl]-
1H-indol-3-yl] tricyclo[3.3.1.13,7] dec-1-yl-methanone]or
[(1-[(N-methylpiperindin-2-yl)
Methyl]-3-(Adamant-1-oyl)indole)].
(RRR) AM 2233 Azepane isomer [(2-iodophenyl)
(1-(1-methylazepan-3-yl)- 1H-indol-3-yl)methanone].
(SSS) CB-13 [1-Naphthalenyl
[4-(pentyoxy)- 1-naphthalenyl]methanone].
(TTT) UR-144 [(1-pentyl-1H-indol-3-yl)
(2,2,3,3-tetramethylcyclopropyl)-methanone].
(UUU) URB 597 [(3'-(aminocarbonyl) [1,1'-biphenyl]-3-yl)-
cyclohexylcarbamate].
SB 209—LS 6921/DI 92 25
(VVV) URB602 [[1,1'-biphenyl]- 3-yl-carbamic acid,
cyclohexyl ester].
(WWW) URB 754 [6-methyl-2-[(4-methylphenyl)
amino]-1-benzoxazin-4-one].
(XXX) XLR-11 or 5-fluoro UR-144
(1-(5-fluoropentyl)-1H-indol-3-yl)
(2,2,3,3-tetramethylcyclopropyl)methanone].
(YYY) AKB48 (Other names include:
N-Adamantyl-1-pentyl-1H-Indazole-3-carboxamide;
1-pentyl-N-tricyclo[3.3.1.13.7]dec-1-yl-1H-indazole-3-
carboxamide).
(ZZZ) 25I-NBOMe (Other names include:
4-Iodo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-
benzeneethanamine);
2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
methyl]ethanamine).
(AAAA) 2C-C-NBOMe (Other names include: 25C-NBOMe;
2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
methyl]ethanamine;
2,5-Dimethoxy-4-chloro-N-(2-methoxybenzyl)
phenethylamine).
(BBBB) 2NE-1 (Other names include: 1-Pentyl-3-
(1-adamantylamido)indole).
(CCCC) STS-135 (Other names include:
N-Adamantyl-1-fluoropentylindole-3- carboxamide
(1-5-fluoropentyl)-N-tricyclo[3.3.1.13.7]dec-1-yl-1H-
indole-3-carboxamide).
(DDDD) PB-22 (Other names include: 1-Pentyl-8-quinolinlyl
ester-1H-indole-2-carboxylic acid).
(EEEE) 5-Fluoro-PB-22 (Other names include:
1-(5-Fluropentyl)-8-quinolinyl ester1H-indole-3-carboxylic
acid).
(FFFF) Benocyclidine (Other names include: BCP, BTCP, and
Benzothiophenylcyclohexylpiperidine).
(GGGG) 25B-NBOMe (Other names include: 2C-B-NBOMe
and 4-Bromo-2,
5-dimenthoxy-N-[(2-Methozyphenyl)methyl]
benzeneethanamine).
(HHHH) APB (Other names include: (2-Aminopropyl)
Benzofuran).
(IIII) AB-PINACA
(N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-
SB 209—LS 6921/DI 92 26
indazole-3-carboxamide.
(JJJJ) AB-FUBINACA
(N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-
1H-indazole-3-carboxamide).
(KKKK) ADB-PINACA
(N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-
indaole-3-carboxamide).
(LLLL) Fluoro ADBICA (N-(1-Amino-3,3-
dimethyl-1-oxobutan-2-yl)-(fluoropentyl)-1H-indole-3-
carboxamide).
(MMMM) APDB (Other names include: -EMA,
-Desoxy-MDA, and (2-Aminopropyl)-2,3-
dihydrobenzofuran).
(NNNN) THJ-2201 (Other names include: AM2201 indazole
analog, Fluoropentyl-JWH-018 indazole, and
5-Fluoro-THJ-018).
(OOOO) AM 2201 benzimidazole analog (Other names
include: FUBIMINA, FTHJ, and (1-(5-fluoropentyl)-1H-
benzo[d]imidazol-2-yl)(naphthalene-1-yl)methanone).
(PPPP) MN-25 (Other names include: 7-methoxy-1-
[2-(4-morpholinyl)ethyl]-N-[1S, 2S, 4R)-1,3,3-
trimethylbicyclo[2.2.1]hept-2-yl]-1H-indole-3-carboxamide
and UR-12).
(QQQQ) FUB-PB-22 (Other names include:
Quinolin-8-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate).
(RRRR) FUD-PB-22 (Other names include:
Naphthalen-1-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate).
(SSSS) 5-Fluoro-AB-PINACA (Other names include:
AB-PINACA 5-fluoro analog and N-(1-amino-3-methyl1-
oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-
carboxaminde).
(TTTT) 4-MePPP (Other names include:
4-methyl-alpha-pyrrolidinopropiophenone).
(UUUU) alpha-PBP (Other names include:
Alpha-pyrrolidinobutiophenone).
(VVVV) AB-CHMINACA (Other names include:
(N-[1-(aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethy
l)-1H-indazole-3-carboxamide).
(WWWW) Mexedrone
(3-methoxy-2-(methylamino)-1-(p-tolyl)propan-1-one).
(XXXX) MT-45,
(1-cyclohexyl-4-(1,2-diphenylethyl)piperazine).
SB 209—LS 6921/DI 92 27
(YYYY) methyl 2-(1-(5-fluoropentyl)- 1H-indazole-3-
carboxamido) -3,3-dimethylbutanoate [5F-ADB;
5F-MDMB-PINACA].
(ZZZZ) methyl 2-(1-(5-fluoropentyl)-1H- indazole-3-
carboxamido)-3-methylbutanoate [5F-AMB].
(AAAAA) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)
-1-(4-fluorobenzyl)- 1H-indazole-3-carboxamide
[ADB-FUBINACA].
(BBBBB) N-(adamantan-1-yl)-1-(5-fluoropentyl)-
1H-indazole-3- carboxamide [5F-APINACA, 5F-AKB48].
(CCCCC) methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-
carboxamido)-3,3-dimethylbutanoate [MDMB-CHMICA,
MMB-CHMINACA].
(DDDDD) methyl 2-(1-(4-fluorobenzyl)-
1H-indazole-3-carboxamido)- 3,3-dimethylbutanoate
[MDMB-FUBINACA].
(EEEEE) N-(1-amino-3,3-dimethyl-1 -oxobutan-2-yl)-1-
(cyclohexylmethyl)- 1H-indazole-3-carboxamide
[MAB-CHMINACA and ADB-CHMINACA].
(FFFFF) Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-
3-carboxamido)- 3-methylbutanoate [FUB-AMB,
MMB-FUBINACA, AMB-FUBINACA].
(GGGGG) 3,4-dichloro-N-[(1dimethylamino)cyclohexylme
thyl]benzamide) [AH7921].
(HHHHH) Naphthalen-1-yl 1-(5-fluoropentyl)-1
H-indole-3-carboxylate (trivial name: NM2201; CBL2201)
(IIIII) 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1
H-indazole-3-carboxamide (trivial name:
4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINA CA;
4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78).
(JJJJJ) methyl 2-(1-(cyclohexylmethyl)-1
H-indole-3-carboxamido)-3-methylbutanoate (trivial names:
MMB-CHMICA, AMB-CHMICA).
(KKKKK) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1
H-pyrrolo[2,3-b]pyridine-3-carboxamide (trivial name:
5F-CUMYL-P7AICA).
(LLLLL) N-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-p
entanone (N-ethylpentylone, ephylone).
(MMMMM) Synthetic cathinone, 1-(1,3-benzodioxol-5-yl)-2-
(ethylamino)- pentan-1-one (N-ethylpentylone, ephylone) and
its optical, positional, and geometric isomers, salts, and salts
of isomers.
SB 209—LS 6921/DI 92 28
(NNNNN) ethyl
2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-
dimethylbutanoate (trivial name: 5F-EDMB-PINACA).
(OOOOO) methyl 2-(1-(5- fluoropentyl)-1H-indole-3-
carboxamido)-3,3-dimethylbutanoate (trivial name:
5F-MDMB-PICA).
(PPPPP) N- (adamantan- 1-yl)- 1-(4-fluorobenzyl)-
1H-indazole-3-carboxamide (trivial names: FUB-AKB48;
FUB-APINACA; AKB48 N- (4-FLUOROBENZYL)).
(QQQQQ) 1-(5- fluoropentyl)-N-(2-phenylpropan-2-yl)-
1H-indazole-3-carboxamide (trivial names:
5F-CUMYL-PINACA; SGT-25).
(RRRRR) (1-(4-fluorobenzyl)-1H-indol-3-
yl)(2,2,3,3-tetramethylcyclopropyl) methanone (trivial name:
FUB-144).
(SSSSS) 4F-MDMB-BINACA.
(TTTTT) N-ethylhexedrone
(2-(ethylamino)-1-phenylhexan-1-one).
(UUUUU) alpha-pyrrolidinohexanophenone
(1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one.
(VVVVV) alpha-pyrrolidinohexiophenone; trivial name:
a-PHP.
(WWWWW) 4'-methyl-alpha-pyrrolidinohexiophenone
(1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one.
(XXXXX) 4-methyl-alphaethylaminopentiophenone
(2-(ethylamino)-1-(4-methylphenyl)pentan-1-one; trivial
name: 4–MEAP.
(YYYYY) 4'-methyl-alphapyrrolidinohexanophenone; trivial
name: MPHP.
(ZZZZZ) alphapyrrolidinoheptaphenone
(1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one; trivial name: PV8.
(AAAAAA) 4'-chloro-alphapyrrolidinovalerophenone (1-(4-
chlorophenyl)-2-(pyrrolidin-1- yl)pentan-1-one.
(BBBBBB) 4'-chloro-alphapyrrolidinopentiophenone; trivial
name: 4-chloro-a-PVP.
(CCCCCC) 4,4'-dimethylaminorex (common name:
4,4'-DMAR).
(2) Any compound structurally derived from
3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane by
substitution at the nitrogen atom of the indole ring by alkyl,
haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
SB 209—LS 6921/DI 92 29
1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
or not further substituted in the indole ring to any extent and
whether or not substituted in the naphthyl ring to any extent.
(3) Any compound structurally derived from 3-(1-naphthoyl)
pyrrole by substitution at the nitrogen atom of the pyrrole ring by
alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl,
2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl,
1-(N-methyl-3- morpholinyl)methyl, or tetrahydropyranylmethyl
group, whether or not further substituted in the pyrrole ring to any
extent and whether or not substituted in the naphthyl ring to any
extent.
(4) Any compound structurally derived from
1-(1-naphthylmethyl)indene by substitution at the 3-position of
the indene ring by alkyl, haloalkyl, cyanoalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
or not further substituted in the indene ring to any extent and
whether or not substituted in the naphthyl ring to any extent.
(5) Any compound structurally derived from 3-phenylacetylindole
by substitution at the nitrogen atom of the indole ring with alkyl,
haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
or not further substituted in the indole ring to any extent and
whether or not substituted in the phenyl ring to any extent.
(6) Any compound structurally derived from
2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position
of the phenolic ring by alkyl, haloalkyl, cyanoalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
or not substituted in the cyclohexyl ring to any extent.
(7) Any compound containing a 3-(benzoyl)indole structure with
substitution at the nitrogen atom of the indole ring by alkyl,
haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
SB 209—LS 6921/DI 92 30
1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
or not further substituted in the indole ring to any extent and
whether or not substituted in the phenyl ring to any extent.
(8) Any compound, except bupropion or a compound listed under
a different schedule, structurally derived from
2-aminopropan-1-one by substitution at the 1-position with either
phenyl, naphthyl, or thiophene ring systems, whether or not the
compound is further modified:
(A) by substitution in the ring system to any extent with alkyl,
alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide
substituents, whether or not further substituted in the ring
system by one or more other univalent substituents;
(B) by substitution at the 3-position with an acyclic alkyl
substituent;
(C) by substitution at the 2-amino nitrogen atom with alkyl,
dialkyl, benzyl, or methoxybenzyl groups; or
(D) by inclusion of the 2-amino nitrogen atom in a cyclic
structure.
(9) Any compound structurally derived from 3-tetramethyl
cyclopropanoylindole with substitution at the nitrogen atom of the
indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl) ethyl,
1-(N-methyl-2-pyrrolidinyl) methyl, 1-(N-methyl-3-
morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
or not further substituted in the indole ring to any extent and
whether or not substituted in the tetramethylcyclopropyl ring to
any extent.
(10) Any compound containing a N-(1-adamantyl)-
1H-indazole-3-carboxamide structure with substitution at the
nitrogen atom of the indazole ring by an alkyl, haloalkyl,
cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl,
1-(N-methyl-2-pyrrolidinyl)methyl,
1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
group, whether or not further substituted at the nitrogen atom of
the carboxamide to any extent, whether or not further substituted
in the indazole ring to any extent, and whether or not further
substituted on the adamantyl ring system to any extent. An
example of this structural class includes AKB48.
(11) Any compound containing a N-(1-adamantyl)-
SB 209—LS 6921/DI 92 31
1H-indole-3-carboxamide structure with substitution at the
nitrogen atom of the indole ring by an alkyl, haloalkyl,
cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl,
1-(N-methyl-2-pyrrolidinyl)methyl,
1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
group, whether or not further substituted at the nitrogen atom of
the carboxamide to any extent, whether or not further substituted
in the indole ring to any extent, and whether or not further
substituted on the adamantyl ring system to any extent. An
example of this structural class includes STS-135.
(12) Any compound containing a 3-(1-adamantoyl)indole
structure with substitution at the nitrogen atom of the indole ring
by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl, or
2-(4-morpholinyl)ethyl, 1-(N-methyl-2- pyrrolidinyl)methyl,
1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
group, whether or not further substituted on the adamantyl ring
system to any extent. An example of this structural class includes
AM-1248.
(13) Any compound determined to be a synthetic drug by rule
adopted under IC 25-26-13-4.1.
SECTION 2. IC 35-48-1-17.4, AS ADDED BY P.L.61-2020,
SECTION 3, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
JULY 1, 2022]: Sec. 17.4. (a) Except as provided in subsections (b)
and (c), "isomer" means an optical isomer.
(b) "Isomer", as used in IC 35-48-2-4(d), means an optical,
positional, or geometric isomer.
(c) "Isomer", as used in section 7 of this chapter, means an optical
or geometric isomer. "Isomer" means an optical, positional, or
geometric isomer.".
Page 2, between lines 17 and 18, begin a new line block indented
and insert:
"Brorphine".
Page 2, delete line 42, begin a new line block indented, and insert:
"2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-
benzimidazole (N-pyrrolidino etonitazene; etonitazepyne)".
Page 3, delete line 1.
Page 6, strike line 1.
SB 209—LS 6921/DI 92 32
Page 6, line 2, strike "includes the optical, position, and geometric
isomers):" and insert "designation:".
Renumber all SECTIONS consecutively.
and when so amended that said bill do pass.
(Reference is to SB 209 as introduced.)
YOUNG M, Chairperson
Committee Vote: Yeas 8, Nays 0.
_____
SENATE MOTION
Madam President: I move that Senate Bill 209 be amended to read
as follows:
Page 1, between the enacting clause and line 1, begin a new
paragraph and insert:
"SECTION 1. IC 15-15-13-6.5, AS ADDED BY P.L.190-2019,
SECTION 7, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
JULY 1, 2022]: Sec. 6.5. As used in this chapter, "hemp product"
means a product derived from, or made by, processing hemp plants or
plant parts including derivatives, extracts, cannabinoids, isomers, acids,
salts, and salts of isomers. However, the term does not include:
(1) smokable hemp (as defined by IC 35-48-1-26.6); or
(2) products that contain a total delta-9-tetrahydrocannabinol
tetrahydrocannabinol concentration of more than three-tenths
of one percent (0.3%) by weight.
SECTION 2. IC 24-4-21-3, AS AMENDED BY P.L.190-2019,
SECTION 24, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
JULY 1, 2022]: Sec. 3. A person may distribute low THC hemp extract
in Indiana only if the distributor has a certificate of analysis prepared
by an independent testing laboratory showing:
(1) that the low THC hemp extract is the product of a batch tested
by the independent testing laboratory;
(2) that the independent testing laboratory determined that the
batch contained not more than three-tenths percent (0.3%) total
delta-9-tetrahydrocannabinol tetrahydrocannabinol (THC),
including precursors and isomers, by weight, based on the testing
of a random sample of the batch; and
(3) the cannabidiol percent present of the low THC hemp extract.
SB 209—LS 6921/DI 92 33
SECTION 3. IC 24-4-21-4, AS ADDED BY P.L.153-2018,
SECTION 9, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
JULY 1, 2022]: Sec. 4. (a) Except as provided in subsection (b), low
THC hemp extract must be distributed in packaging that contains the
following information:
(1) A scannable bar code or QR code linked to a document that
contains information with respect to THE manufacture of the low
THC hemp extract, including the:
(A) batch identification number;
(B) product name;
(C) batch date;
(D) expiration date, which must be not more than two (2) years
from the date of manufacture;
(E) batch size;
(F) total quantity produced;
(G) ingredients used, including the:
(i) ingredient name;
(ii) name of the company that manufactured the ingredient;
(iii) company or product identification number or code, if
applicable; and
(iv) ingredient lot number; and
(H) download link for a certificate of analysis for the low THC
hemp extract.
(2) The batch number.
(3) The Internet address of a web site to obtain batch information.
(4) The expiration date.
(5) The number of milligrams of low THC hemp extract.
(6) The manufacturer.
(7) The fact that the product contains not more than three-tenths
percent (0.3%) total delta-9-tetrahydrocannabinol
tetrahydrocannabinol (THC), including precursors and isomers,
by weight.
(b) Before July 1, 2018, low THC hemp extract may be distributed
in Indiana without having met the requirements described in subsection
(a).".
Page 1, line 5, delete "compound:" and insert "compound and its
isomers, salts, and salts of isomers:".
Page 11, between lines 5 and 6, begin a new paragraph and insert:
"SECTION 6. IC 35-48-1-17.5, AS AMENDED BY P.L.190-2019,
SECTION 28, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
JULY 1, 2022]: Sec. 17.5. (a) "Low THC hemp extract" means a
substance or compound that:
SB 209—LS 6921/DI 92 34
(1) is derived from or contains any part of the plant Cannabis
sativa L. that meets the definition of hemp under IC 15-15-13-6;
(2) contains not more than three-tenths percent (0.3%) total
delta-9-tetrahydrocannabinol tetrahydrocannabinol (THC),
including precursors and isomers, by weight; and
(3) contains no other controlled substances.
(b) The term does not include:
(1) the harvested reproductive organ, whether immature or
mature, of the female hemp plant; or
(2) smokable hemp.".
Renumber all SECTIONS consecutively.
(Reference is to SB 209 as printed January 21, 2022.)
BROWN L
SB 209—LS 6921/DI 92